C
Cengild Medical Bhd
KLSE:CENGILD
Cengild Medical Bhd
KLSE:CENGILD
Price:
0.225
MYR
-2.17%
Market Closed
Market Cap:
187.4m
MYR
Balance Sheet
Balance Sheet Decomposition
Cengild Medical Bhd
Cengild Medical Bhd
Balance Sheet Decomposition is not available for
Cengild Medical Bhd
Cengild Medical Bhd
Balance Sheet
Cengild Medical Bhd
Cengild Medical Bhd
Currency: MYR
| Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
1
|
6
|
1
|
6
|
1
|
2
|
0
|
|
| Cash |
1
|
1
|
6
|
1
|
6
|
1
|
2
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
6
|
81
|
98
|
88
|
73
|
|
| Total Receivables |
2
|
3
|
4
|
5
|
6
|
6
|
7
|
12
|
|
| Accounts Receivables |
1
|
3
|
3
|
4
|
5
|
5
|
7
|
9
|
|
| Other Receivables |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
3
|
|
| Inventory |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
4
|
5
|
11
|
13
|
94
|
106
|
99
|
98
|
|
| PP&E Net |
43
|
41
|
36
|
33
|
24
|
24
|
30
|
76
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
30
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
18
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
|
| Total Assets |
47
N/A
|
46
-2%
|
47
+2%
|
46
-2%
|
120
+160%
|
132
+10%
|
132
+1%
|
180
+36%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
3
|
4
|
5
|
4
|
3
|
4
|
9
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
|
| Short-Term Debt |
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
4
|
5
|
3
|
1
|
1
|
2
|
2
|
|
| Other Current Liabilities |
5
|
4
|
5
|
3
|
7
|
7
|
4
|
8
|
|
| Total Current Liabilities |
10
|
11
|
13
|
11
|
12
|
11
|
15
|
20
|
|
| Long-Term Debt |
33
|
29
|
24
|
21
|
15
|
14
|
6
|
45
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Liabilities |
43
N/A
|
40
-6%
|
37
-7%
|
32
-14%
|
27
-17%
|
26
-4%
|
21
-17%
|
66
+212%
|
|
| Equity | |||||||||
| Common Stock |
13
|
13
|
13
|
12
|
82
|
87
|
87
|
87
|
|
| Retained Earnings |
8
|
7
|
3
|
2
|
11
|
19
|
24
|
27
|
|
| Total Equity |
4
N/A
|
6
+34%
|
10
+68%
|
14
+41%
|
93
+575%
|
106
+14%
|
111
+5%
|
114
+3%
|
|
| Total Liabilities & Equity |
47
N/A
|
46
-2%
|
47
+2%
|
46
-2%
|
120
+160%
|
132
+10%
|
132
+1%
|
180
+36%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
819
|
819
|
819
|
819
|
819
|
833
|
833
|
833
|
|
Switch to:
Switch to:
See Also
Discover More
